These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15498684)

  • 1. Tritium labelling of dopaminergic ligands domperidone and (+/-)-7-hydroxy DPAT.
    Pounds S; Seguin RJ; Filer CN
    Appl Radiat Isot; 2005 Jan; 62(1):49-53. PubMed ID: 15498684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5'-(18)F-fluoropentyl)aminotetralin ((18)F-5-OH-FPPAT) in rodents and nonhuman primates.
    Shi B; Narayanan TK; Christian BT; Chattopadhyay S; Mukherjee J
    Nucl Med Biol; 2004 Apr; 31(3):303-11. PubMed ID: 15028242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu opiate active substances trefentanil and naloxonazine: tritiation at high specific activity.
    Ahern DG; Egan JA; Seguin RJ; Filer CN
    Appl Radiat Isot; 2005 Aug; 63(2):189-92. PubMed ID: 15927477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tritiation and characterization of several suicide substrate enzyme inactivators.
    Egan JA; Filer CN
    Appl Radiat Isot; 2014 Dec; 94():302-305. PubMed ID: 25305521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
    de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W
    J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colforsin analogues: tritiation and characterization.
    Egan JA; Nugent RP; Filer CN
    Appl Radiat Isot; 2004 Dec; 61(6):1269-72. PubMed ID: 15388120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tritiation of nonpeptide substance P antagonist CP-96,345 and its azido analogue. Synthetic and characterization details.
    Egan JA; Filer CN
    Appl Radiat Isot; 2003; 59(5-6):333-5. PubMed ID: 14622931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2 receptor activation in distinct striatal neurons in comparison with D3 receptors.
    Sasa M; Ishihara K; Amano T; Matsubayashi H; Momiyama T; Todo N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):97-100. PubMed ID: 9201730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
    Yoshikawa T; Yoshida N; Oka M
    Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethyl-³H analogues of plant natural products: Biologically active proxy radioligands via vinyl group tritiation.
    Orphanos D; Filer CN
    Appl Radiat Isot; 2016 Jan; 107():203-205. PubMed ID: 26520478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDV3100: Tritium labeling at high specific activity.
    Byon C; Chakravarty S; Filer CN; Jain R; Maniscalco MP
    Appl Radiat Isot; 2016 Feb; 108():35-37. PubMed ID: 26686973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphinan alkaloids labeled with tritium: synthesis and applications.
    Filer CN
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):639-48. PubMed ID: 25196025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of [15, 16- ³H] beta-funaltrexamine.
    Filer CN; Seguin RJ
    J Labelled Comp Radiopharm; 2013 May; 56(5):310-1. PubMed ID: 24285378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
    Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
    Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palladium(II)-Mediated C-H Tritiation of Complex Pharmaceuticals.
    Yang H; Dormer PG; Rivera NR; Hoover AJ
    Angew Chem Int Ed Engl; 2018 Feb; 57(7):1883-1887. PubMed ID: 29314462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tritiation of several antihypertensive agents at high specific activity.
    Andrews JR; Egan JA; Filer CN
    Appl Radiat Isot; 2008 Oct; 66(10):1392-5. PubMed ID: 18424053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel (R)-2-amino-5-fluorotetralins: dopaminergic antagonists and inverse agonists.
    Malmberg A; Höök BB; Johansson AM; Hacksell U
    J Med Chem; 1996 Oct; 39(22):4421-9. PubMed ID: 8893836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]domperidone binding to the kidney inner medullary collecting duct dopamine-2K (DA2K) receptor.
    Huo T; Healy DP
    J Pharmacol Exp Ther; 1991 Aug; 258(2):424-8. PubMed ID: 1830902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.